Explore GPC3/Glypican 3 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
| Target ID |
GM-T25726
|
| Target Name |
GPC3/Glypican 3
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
2719
|
| Gene ID |
100054222 (Equus caballus), 101094739 (Felis catus), 14734 (Mus musculus), 25236 (Rattus norvegicus) 2719 (Homo sapiens), 481056 (Canis lupus familiaris), 615239 (Bos taurus), 706773 (Macaca mulatta)
|
| Target Alternative Names |
DGSX,GPC3,GTR2-2,Glypican 3,Glypican-3,Gpc3,Intestinal protein OCI-5,MXR7,OCI-5,SDYS,SGB,SGBS,SGBS1
|
| Uniprot Accession |
Q8CFZ4,P13265,P51654
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target, Immuno-oncology Target, INN Index
|
| Disease |
cancer
|
| Disease from KEGG |
Proteoglycans in cancer
|
| Gene Ensembl |
ENSECAG00000010025, ENSMUSG00000055653, ENSG00000147257, ENSCAFG00845031100, ENSBTAG00000020406, ENSMMUG00000009622
|
| Target Classification |
Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA)
|
Pre-made viral vector of GPC3/Glypican 3 cDNA Clones/ORF Plasmid
GPC3/Glypican 3 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo2719 | Pre-made Human GPC3/SGB/DGSX siRNA oligo Duplex | 2719 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo25236 | Pre-made Rat Gpc3/OCI-5 siRNA oligo Duplex | 25236 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo14734 | Pre-made Mouse Gpc3/OCI-5 siRNA oligo Duplex | 14734 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo706773 | Pre-made Cynomolgus/Rhesus macaque GPC3 siRNA oligo Duplex | 706773 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101094739 | Pre-made Cat/Feline GPC3 siRNA oligo Duplex | 101094739 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo481056 | Pre-made Dog/Canine GPC3 siRNA oligo Duplex | 481056 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo615239 | Pre-made Bovines/Cattle GPC3 siRNA oligo Duplex | 615239 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100054222 | Pre-made Equine/Horse GPC3 siRNA oligo Duplex | 100054222 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
GPC3/Glypican 3 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T25726-Ab | Human | Anti-Human GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T25726-Ab | Rat | Anti-Rat GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T25726-Ab | Mouse | Anti-Mouse GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T25726-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T25726-Ab | Cat/Feline | Anti-Cat/Feline GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T25726-Ab | Dog/Canine | Anti-Dog/Canine GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T25726-Ab | Bovines/Cattle | Anti-Bovines/Cattle GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T25726-Ab | Equine/Horse | Anti-Equine/Horse GPC3/Glypican 3 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GPC3/Glypican 3 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T25726-Ag | Human | Human GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T25726-Ag | Rat | Rat GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T25726-Ag | Mouse | Mouse GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T25726-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T25726-Ag | Cat/Feline | Cat/Feline GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T25726-Ag | Dog/Canine | Dog/Canine GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T25726-Ag | Bovines/Cattle | Bovines/Cattle GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T25726-Ag | Equine/Horse | Equine/Horse GPC3/Glypican 3 VLP (virus-like particle) | HEK293 | Products Developing |